UNH icon

UnitedHealth

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 28.1%
Negative

Negative
The Motley Fool
8 hours ago
Is UnitedHealth Group Stock a Buy, Sell, or Hold in 2026?
Rising medical expenses have been weighing down UnitedHealth's margins in recent quarters. The stock crashed last year after missing expectations, pulling its guidance, and changing its CEO.
Is UnitedHealth Group Stock a Buy, Sell, or Hold in 2026?
Positive
Reuters
16 hours ago
UnitedHealth to accelerate Medicare Advantage payments to some rural hospitals
UnitedHealth's health insurance unit said on Wednesday it has launched a pilot program aimed at speeding up Medicare Advantage payments by 50% on average to support independent rural hospitals in some states.
UnitedHealth to accelerate Medicare Advantage payments to some rural hospitals
Negative
The Motley Fool
yesterday
Should You Buy Shares of UnitedHealth In January?
UnitedHealth faced a series of headwinds in 2025, resulting in a 34% decline in its stock price. The health insurance giant has taken several steps to address problems.
Should You Buy Shares of UnitedHealth In January?
Positive
Seeking Alpha
yesterday
UnitedHealth: Inflection Confirmation Imminent
UnitedHealth Group Incorporated navigated a turbulent 2025 with management changes, mispriced costs, and a surging medical cost ratio, but revenue growth remained robust. We expect 2026 EPS guidance in the high teens, signaling a double-digit rebound off 2025's $16.25–$16.50 floor, with confirmation of inflection imminent at the upcoming earnings. Dividend growth and a 2.8% yield provide income while awaiting margin recovery; buybacks are paused but likely to resume as cash flow improves.
UnitedHealth: Inflection Confirmation Imminent
Positive
Seeking Alpha
yesterday
UnitedHealth Could Re-Take Its All-Time High In 2026
Recently the U.S. Senate approved another round of Affordable Care Act (ACA) subsidy extensions. Trump said he "might" veto the subsidy extensions, but he did not conclusively say he would. UnitedHealth's stock got beaten down partially because the subsidies were expected to expire. The subsidies did in fact expire, but were re-instated and extended. Just recently, the company re-affirmed its full year earnings guidance for 2026, a number that implies significant growth over the trailing 12 month period.
UnitedHealth Could Re-Take Its All-Time High In 2026
Neutral
CNBC Television
2 days ago
Final Trades: Capital One, UnitedHealth, Regeneron and Alibaba
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Capital One, UnitedHealth, Regeneron and Alibaba
Neutral
Business Wire
2 days ago
New Independent Studies: Medicare Advantage Delivers Greater Value to the Federal Government and Beneficiaries than Traditional Medicare
--(BUSINESS WIRE)--UnitedHealth Group today announced the release of two new, independent commissioned actuarial studies. The findings, from the independent actuarial and research firm Milliman, using estimates of 2025 costs, summarize the value of Medicare Advantage (MA) both to the government and beneficiaries. Milliman found that: MA costs the federal government 9% less than traditional Medicare. MA out-of-pocket costs are 53% less than in traditional Medicare for a non-dual eligible aged-in.
New Independent Studies: Medicare Advantage Delivers Greater Value to the Federal Government and Beneficiaries than Traditional Medicare
Negative
Reuters
2 days ago
Senate report says UnitedHealth used aggressive tactics to boost medicare payments, WSJ reports
Health insurer UnitedHealth Group used aggressive tactics to gather diagnoses that can boost Medicare Advantage payments, the Wall Street Journal reported on Monday, citing a U.S. Senate committee investigating the company's practices.
Senate report says UnitedHealth used aggressive tactics to boost medicare payments, WSJ reports
Negative
WSJ
2 days ago
UnitedHealth Group deployed aggressive tactics to collect payment-boosting diagnoses for its Medicare Advantage members, a Senate committee investigating the company's practices said
Sen. Chuck Grassley launched an investigation last year following Wall Street Journal reports examining the company's Medicare Advantage practices.
UnitedHealth Group deployed aggressive tactics to collect payment-boosting diagnoses for its Medicare Advantage members, a Senate committee investigating the company's practices said
Positive
Forbes
3 days ago
The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips
The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite. The index's top payers dish up to 6.8%.
The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips